Top Markets
Coin of the day
BioHarvest Sciences Inc. Common Stock BioHarvest Sciences Inc. Common Stock

BioHarvest Sciences Inc. Common Stock

BHST
Classifica tra le azioni #27032
BioHarvest Sciences Inc. functions as a biotechnology firm with operations... BioHarvest Sciences Inc. functions as a biotechnology firm with operations segmented into Nutraceuticals and Pharmaceuticals. A key innovation is its proprietary botanical synthesis platform technology, which allows for the cultivation of active ingredients found within plant enzymes or cells. The company harnesses this advanced technology to craft evidence-based and clinically validated therapeutic products for both its nutraceutical and pharmaceutical offerings. Beyond its own development, it also provides contract development and manufacturing services. Its product portfolio includes various wellness items, notably VINIA, a dietary supplement derived from red grape cells, which delivers the full spectrum of polyphenols naturally present in red grapes. The company conducts business in Israel and the United States, with its corporate base in Vancouver, Canada.
Prezzo delle azioni
$2.06
Ultima sincronizzazione: 2026-08-19
Capitalizzazione di mercato
$35.61M
Variazione (1 giorno)
-2.61%
Variazione (1 anno)
-77.76%
Paese
CA
Scambia BioHarvest Sciences Inc. Common Stock (BHST)
Ricavi di BioHarvest Sciences Inc. Common Stock (BHST)
Ricavi nel Aug 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di BioHarvest Sciences Inc. Common Stock, i ricavi attuali dell'azienda (TTM) sono pari a 0. Nel 2026, l'azienda ha registrato ricavi di 0 uguale a i ricavi dell'anno 2026, che erano pari a 0. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per BioHarvest Sciences Inc. Common Stock da 2026 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
Non abbastanza dati per le date fornite.
Ricavi di aziende simili o concorrenti